Health

Results: 685-696 of 8097

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment

DATROWAY® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy

EDX Medical’s New Advanced Bowel Cancer Testing Service to Launch in UK to Improve Early Detection

Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector

PR Newswire associated0

Jazz Pharmaceuticals to Participate in Upcoming Investor Events

TruMerit and NAPNAP Team Up to Develop a Global Micro-credential for Pediatric Nursing Care

Incyte Announces European Commission Approval of Minjuvi® (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma

Tiziana Life Sciences to Ring the Closing Bell at Nasdaq

Amicus Therapeutics Announces Recipients of Inaugural Funding Programme for the Pompe Disease Community

Tiziana Life Sciences Doses First Patient in Phase 2 Alzheimer’s Clinical Trial

PR Newswire associated0

Rona Therapeutics Unveils the Global First Bi-valent PCSK9-LPA siRNA into Clinical Development for Cardiovascular Risk Reduction

AVeta Medical Appoints Karen Noblett as New CEO